Second messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC-3 and DU-145

被引:21
|
作者
Stubbs, AP
Lalani, EN
Stamp, GWH
Hurst, H
Abel, P
Waxman, J
机构
[1] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT HISTOPATHOL, LONDON W12 0NN, ENGLAND
[2] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT ONCOL, LONDON W12 0NN, ENGLAND
[3] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT ICRF ONCOL UNIT, LONDON W12 0NN, ENGLAND
[4] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT SURG, LONDON W12 0NN, ENGLAND
来源
FEBS LETTERS | 1996年 / 383卷 / 03期
关键词
androgen receptor; electromobility shift assay; prostate cancer;
D O I
10.1016/0014-5793(96)00241-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A theoretical pathway of transcriptional regulation of the androgen receptor (AR) gene is via a cAMP response element (CRE) present in its promoter region (-508 to -501), After 20 h of stimulation with 8-bromo-cAMP, AR mRNA was upregulated in LNCaP but not in either PC-3 or DU-145 cell lines, We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and competable protein interactions with CREB, The ability to regulate AR gene transcription via the second messenger pathway is lost in the PC-3 and DU-145 cell lines, This may be an important primary mechanism of androgen insensitivity in prostate cancer.
引用
收藏
页码:237 / 240
页数:4
相关论文
共 42 条
  • [1] Second messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC-3 and DU-145 (vol 383, pg 237, 1996)
    Stubbs, AP
    Lalani, EN
    Stampa, GWH
    Hurst, H
    Abel, P
    Waxman, J
    FEBS LETTERS, 1996, 390 (02) : 240 - 240
  • [2] DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: Implications for the androgen receptor functions and regulation
    Alimirah, F
    Chen, JM
    Basrawala, Z
    Xin, H
    Choubey, D
    FEBS LETTERS, 2006, 580 (09): : 2294 - 2300
  • [3] ESTRAMUSTINE-INDUCED MITOTIC ARREST IN 2 HUMAN PROSTATIC-CARCINOMA CELL-LINES DU-145 AND PC-3
    HARTLEYASP, B
    PROSTATE, 1984, 5 (01): : 93 - 100
  • [4] Etoposide sensitivity of human prostatic cancer cell lines PC-3, DU 145 and LNCaP
    Salido, M
    Larrán, J
    López, A
    Vilches, J
    Aparicio, J
    HISTOLOGY AND HISTOPATHOLOGY, 1999, 14 (01) : 125 - 134
  • [5] Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145
    Roomi, M. W.
    Kalinovsky, T.
    Rath, M.
    Niedzwiecki, A.
    ONCOLOGY REPORTS, 2011, 26 (06) : 1407 - 1413
  • [6] Formation of a novel topotecan metabolite in the hormone-independent human prostate carcinoma cell lines DU-145 and PC-3
    Platzer, P
    Herzog, W
    Thalhammer, T
    Hamilton, G
    Haberl, I
    Jäger, W
    ANTICANCER RESEARCH, 1998, 18 (4A) : 2737 - 2741
  • [7] DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines
    Adjakly, Mawussi
    Bosviel, Remy
    Rabiau, Nadege
    Boiteux, Jean-Paul
    Bignon, Yves-Jean
    Guy, Laurent
    Bernard-Gallon, Dominique
    EPIGENOMICS, 2011, 3 (06) : 795 - 803
  • [8] A monoclonal antibody cytolytic to androgen independent DU145 and PC3 human prostatic carcinoma cells
    Talwar, GP
    Gupta, R
    Gupta, SK
    Malhotra, R
    Khanna, R
    Mitra, DK
    Sehgal, S
    Minz, R
    Kumar, A
    PROSTATE, 2001, 46 (03): : 207 - 213
  • [9] Experimental therapy of PC-3 and DU-145 human androgen-independent prostate cancers with targeted cytotoxic analog of somatostatin AN-162
    Rick, Ferenc
    Abi-Chaker, Andrew
    Szalontay, Luca
    Block, Norman L.
    Halmos, Gabor
    Schally, Andrew V.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [10] Sphingosine induces apoptosis in androgen-independent human prostatic carcinoma DU-145 cells by suppression of bcl-X-L gene expression
    Shirahama, T
    Sakakura, C
    Sweeney, EA
    Ozawa, M
    Takemoto, M
    Nishiyama, K
    Ohi, Y
    Igarashi, Y
    FEBS LETTERS, 1997, 407 (01) : 97 - 100